https://www.selleckchem.com/pr....oducts/AR-42-HDAC-42
Catheter ablation (CA) is an established treatment for patients with symptomatic atrial fibrillation (AF). The purpose of this study was to evaluate the safety and efficacy of single CA in AF patients with extreme obesity (body mass index [BMI] ≥ 40 kg/m2) and its long-term impact on body weight. Patients with BMI ≥40 kg/m2 who underwent CA at the Ohio State University between 2012 and 2016 were included. #link# The primary efficacy endpoint was no atrial arrhythmia lasting 30 seconds without anti-arrhythmic drugs during 1-ye
Like
Comment
Share
